Karsak M - Search Results

1

Cannabinoids in Glioblastoma Therapy: New Applications for Old Drugs.

Dumitru CA, Sandalcioglu IE, Karsak M. Dumitru CA, et al. Among authors: karsak m. Front Mol Neurosci. 2018 May 16;11:159. doi: 10.3389/fnmol.2018.00159. eCollection 2018. Front Mol Neurosci. 2018. PMID: 29867351 Free PMC article. Review.

2

Systematic Affinity Purification Coupled to Mass Spectrometry Identified p62 as Part of the Cannabinoid Receptor CB2 Interactome.

Sharaf A, Mensching L, Keller C, Rading S, Scheffold M, Palkowitsch L, Djogo N, Rezgaoui M, Kestler HA, Moepps B, Failla AV, Karsak M. Sharaf A, et al. Among authors: karsak m. Front Mol Neurosci. 2019 Sep 20;12:224. doi: 10.3389/fnmol.2019.00224. eCollection 2019. Front Mol Neurosci. 2019. PMID: 31616248 Free PMC article.

3

Dynein Light Chain Protein Tctex1: A Novel Prognostic Marker and Molecular Mediator in Glioblastoma.

Dumitru CA, Brouwer E, Stelzer T, Nocerino S, Rading S, Wilkens L, Sandalcioglu IE, Karsak M. Dumitru CA, et al. Among authors: karsak m. Cancers (Basel). 2021 May 27;13(11):2624. doi: 10.3390/cancers13112624. Cancers (Basel). 2021. PMID: 34071761 Free PMC article.

4

Impact of the Endocannabinoid System on Bone Formation and Remodeling in p62 KO Mice.

Keller C, Yorgan TA, Rading S, Schinke T, Karsak M. Keller C, et al. Among authors: karsak m. Front Pharmacol. 2022 Mar 22;13:858215. doi: 10.3389/fphar.2022.858215. eCollection 2022. Front Pharmacol. 2022. PMID: 35392569 Free PMC article.

5

Stable Adult Hippocampal Neurogenesis in Cannabinoid Receptor CB2 Deficient Mice.

Mensching L, Djogo N, Keller C, Rading S, Karsak M. Mensching L, et al. Among authors: karsak m. Int J Mol Sci. 2019 Aug 1;20(15):3759. doi: 10.3390/ijms20153759. Int J Mol Sci. 2019. PMID: 31374821 Free PMC article.

6

Monitoring Cannabinoid CB2 -Receptor Mediated cAMP Dynamics by FRET-Based Live Cell Imaging.

Mensching L, Rading S, Nikolaev V, Karsak M. Mensching L, et al. Among authors: karsak m. Int J Mol Sci. 2020 Oct 23;21(21):7880. doi: 10.3390/ijms21217880. Int J Mol Sci. 2020. PMID: 33114208 Free PMC article.

7

Editorial: Therapeutic potential of the cannabinoid CB2 receptor.

Smoum R, Grether U, Karsak M, Vernall AJ, Park F, Hillard CJ, Pacher P. Smoum R, et al. Among authors: karsak m. Front Pharmacol. 2022 Oct 7;13:1039564. doi: 10.3389/fphar.2022.1039564. eCollection 2022. Front Pharmacol. 2022. PMID: 36278235 Free PMC article. No abstract available.

8

Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse model of ALS.

Pasquarelli N, Engelskirchen M, Hanselmann J, Endres S, Porazik C, Bayer H, Buck E, Karsak M, Weydt P, Ferger B, Witting A. Pasquarelli N, et al. Among authors: karsak m. Neuropharmacology. 2017 Sep 15;124:157-169. doi: 10.1016/j.neuropharm.2017.03.037. Epub 2017 Mar 31. Neuropharmacology. 2017. PMID: 28373073

9

Acute Liver Injury after CCl₄ Administration is Independent of Smad7 Expression in Myeloid Cells.

Endig J, Unrau L, Sprezyna P, Rading S, Karsak M, Goltz D, Heukamp LC, Tiegs G, Diehl L. Endig J, et al. Among authors: karsak m. Int J Mol Sci. 2019 Nov 6;20(22):5528. doi: 10.3390/ijms20225528. Int J Mol Sci. 2019. PMID: 31698731 Free PMC article.

10

Cannabinoid receptor 2 expression modulates Gβ(1)γ(2) protein interaction with the activator of G protein signalling 2/dynein light chain protein Tctex-1.

Nagler M, Palkowitsch L, Rading S, Moepps B, Karsak M. Nagler M, et al. Among authors: karsak m. Biochem Pharmacol. 2016 Jan 1;99:60-72. doi: 10.1016/j.bcp.2015.09.017. Epub 2015 Sep 26. Biochem Pharmacol. 2016. PMID: 26410677

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters